Recent Press Releases

Profectus BioSciences Receives $9.5 Million Department of Defense Funding to Manufacture Trivalent VesiculoVax™-Vectored Vaccine to Protect Against all Ebola and Marburg Viruses

- Funding to support GMP manufacture of VesiculoVax™-vectored vaccines for Zaire-Ebola virus, Sudan-Ebola virus, and Angola-Marburg virus that will be blended into a single formulation; rapid...

Impax Announces R&D Reorganization Designed to Yield Process Improvements and Efficiencies

HAYWARD -- Impax Laboratories, Inc. (NASDAQ: IPXL) today announced a reorganization of its research and development (R&D) organizations and a prioritization of the project portfolios within the...

U.S. FDA Cardiovascular and Renal Drugs Advisory Committee Makes Recommendation on Daiichi Sankyo's Once-Daily SAVAYSA™ (edoxaban) for the Reduction in Risk of Stroke and Systemic Embolic Events in Patients with Non-Valvular Atrial Fibrillation

TOKYO -- Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) today announced that the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee voted 9...

Alnylam Pharmaceuticals (ALNY) Appoints Pushkal Garg, M.D., Senior Vice President, Clinical Development

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today the appointment of Pushkal Garg, M.D., to the position of Senior...

Aileron Therapeutics Expands Senior Management Team

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aileron Therapeutics, Inc., a clinical stage biopharmaceutical company that is developing first-in-class therapeutics based on its proprietary Stapled Peptide drug...

Cesca Therapeutics Hunts For A New CEO

RANCHO CORDOVA, Calif., Oct. 29, 2014 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (Nasdaq:KOOL), an autologous cell-based regenerative medicine company, today announced it intends to embark on a...

Nabsys Appoints Anthony Shuber as Chief Scientific Officer

Accomplished molecular biologist to guide company towards cancer genomics development PROVIDENCE, R.I.--(BUSINESS WIRE)--Nabsys, Inc., a life sciences company pioneering semiconductor-based tools for...

Ciclofilin Pharmaceuticals Appoints Stephen F. Keane As Senior VP Of Corporate Development

SAN DIEGO, Oct. 27, 2014 (GLOBE NEWSWIRE) -- Ciclofilin Pharmaceuticals Inc. ("Ciclofilin" or the "Company"), a developer of broad spectrum antiviral medications, announced today...

Sirona Biochem Names Attila Hajdu As Chief Business Development Officer

Vancouver, British Columbia – October 27, 2014 – Sirona Biochem Corp. (TSX-V: SBM, FSE: ZSB) announces that it has named Mr. Attila Hajdu as Chief Business Development Officer. Prior to...

Epizyme Announces Departure of Chief Medical Officer Eric Hedrick, M.D.

-- Chief Development Officer Peter Ho, M.D., Ph.D., will continue to oversee clinical development, as well as translational medicine and regulatory activities -- CAMBRIDGE, Mass.--(BUSINESS...

Clarus Ventures Adds Barry Gertz, M.D., Ph.D., And Ari Brettman, M.D., To Cambridge Office

CAMBRIDGE, Mass. and FOSTER CITY, Calif., Oct. 27, 2014 /PRNewswire/ -- Clarus Ventures, LLC ("Clarus Ventures"), a leading life sciences investment firm, announced today the appointments...

Raze Therapeutics Appoints Mikel Moyer, PhD, as Vice President, Molecular Discovery

– Drug Discovery Leader with Extensive Oncology Experience – CAMBRIDGE, Mass.--(BUSINESS WIRE)--Raze Therapeutics, a biotechnology company leading the discovery and development of a new...

REGENXBIO Appoints Dr. Stephen Yoo As Chief Medical Officer

WASHINGTON, Oct. 28, 2014 (GLOBE NEWSWIRE) -- REGENXBIO Inc. today announced the appointment of Stephen Yoo, M.D. as Chief Medical Officer, effective immediately. Dr. Yoo will oversee the development...

Catalyst Pharmaceutical Partners, Inc. (CPRX) Appoints David J. Caponera As Vice President Patient Advocacy And Reimbursement

CORAL GABLES, Fla., Oct. 28, 2014 (GLOBE NEWSWIRE) -- Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) (Catalyst Pharmaceuticals), a biopharmaceutical company focused on developing and...

Loxo Oncology (LOXO) Appoints Chief Medical Officer, New Director

STAMFORD, Conn., Oct. 28, 2014 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO) ("Loxo"), a biopharmaceutical company focused on developing targeted cancer therapies for...

Synthetic Genomics, Inc. Appoints Oliver Fetzer, Ph.D., MBA As Chief Executive Officer

LA JOLLA, Calif., Oct. 27, 2014 /PRNewswire/ -- Synthetic Genomics, Inc. (SGI), a synthetic biology company commercializing genomic technologies to revolutionize several industries, today announced...

Cerulean Pharma Inc. (CERU) CEO Steps Down

Cerulean Announces Management Changes CAMBRIDGE, Mass., Oct. 27, 2014 (GLOBE NEWSWIRE) -- Cerulean Pharma Inc. (Nasdaq:CERU), a leader in Dynamic Tumor Targeting™, today announced that Oliver...

Imago BioSciences Announces $26.5 Million Financing Led by Clarus Ventures

SAN FRANCISCO, Oct. 31, 2014 /PRNewswire/ -- Imago BioSciences, Inc., a biotech company developing innovative therapeutics, today announced a $26.5 million Series A financing led by Clarus Ventures...

AusBiotech Ltd. Announces New Chairman And Directors

AusBiotech Ltd. Announces New Chairman And Directors AusBiotech has announced that a new Chairman and three new directors were appointed to its Board at the Annual General Meeting on the Gold Coast...

Affinivax Appoints Frances K. Heller To Board of Directors

Affinivax Appoints Frances K. Heller To Board of Directors CAMBRIDGE, Mass.--(BUSINESS WIRE)--Affinivax Inc., a biotechnology company dedicated to developing novel vaccines, today announced that it...